Research & Studies
Share your love
FDA Greenlights Genentech’s Vabysmo | OBN
The FDA has approved Genentech’s Vabysmo (faricimab-svoa) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), marking the first bispecific antibody approved for the eye. Vabysmo is also the first and only FDA-approved injectable eye…
Alcon’s New Eye Health Education and Training Center I OBN
Alcon has officially inaugurated the new Alcon Experience Center (AEC) in Barcelona, one of Europe’s largest eye health education and training facilities, providing eye care professionals with the chance to learn about and practice the latest advancements in ophthalmology and…
AAO Guidelines For Standardizing Images In Ophthalmology I OBN
Ophthalmic imaging device makers have been urged to standardize image formats in order to adhere to the Digital Imaging and Communications in Medicine (DICOM) standard, according to a recent report by the American Academy of Ophthalmology. By establishing a uniform…
Rayner’s RayOne EMV IOL Approved By FDA I OBN
Since producing the first IOL in the world in 1949, Rayner has led the way in innovation, focusing on giving you and your patients the best IOLs and opthalmic solutions while always being guided by research to enhance patient outcomes…